The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Biosimilar Therapeutic Peptides Market Between 2026 And 2030?
The biosimilar therapeutic peptides market has experienced substantial expansion in recent years. This market is anticipated to increase from $3.5 billion in 2025 to $3.9 billion in 2026, with a compound annual growth rate (CAGR) of 11.5%. Historically, the expansion can be credited to the constrained availability of biosimilar peptides, a reliance on innovative peptide therapies, the increasing prevalence of cancer and metabolic disorders, greater awareness of peptide-based treatments, and the development of parenteral administration methods.
The biosimilar therapeutic peptides market size is projected to experience swift expansion over the coming years. This market is anticipated to reach $6.11 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.9%. Factors contributing to this growth during the forecast period include the introduction of combination and prolonged-action peptides, the expansion of generic peptide manufacturing, the increasing use of transdermal delivery methods, heightened investment in peptide research and development, and rising healthcare spending on peptide therapeutics. Key trends expected within the forecast timeframe encompass a growing need for biosimilar therapeutic peptides in cancer therapy, the development of peptide-based treatments for metabolic and cardiovascular conditions, a greater uptake of long-acting and combination peptides, the broadening of parenteral and transdermal administration pathways, and an emphasis on affordable generic peptides along with their availability in developing markets.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3423&type=smp
Which Important Drivers Are Guiding The Biosimilar Therapeutic Peptides Market Growth?
The increasing occurrence of chronic diseases is anticipated to propel the biosimilar therapeutic peptide market. These enduring medical conditions demand ongoing management and treatment, frequently spanning years or an entire lifetime. The growing prevalence of such diseases creates a substantial need for economical treatment solutions, positioning biosimilar therapeutic peptides as a compelling option due to their affordability and potential to enhance patient access while bolstering healthcare system sustainability. Furthermore, market expansion is supported by regulatory endorsements and robust clinical evidence. For example, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, a report in April 2025 indicated that roughly 194 million U.S. adults, representing 76.4%, had at least one chronic condition in 2023. This prevalence was noted at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the widespread presence of chronic illnesses is projected to drive the growth of the biosimilar therapeutic peptides market.
How Is The Biosimilar Therapeutic Peptides Market Broken Down By Segment Categories?
The biosimilar therapeutic peptides market covered in this report is segmented –
1) By Type: Innovative, Generic
2) By Route Of Administration: Parenteral Route, Transdermal Route, Other Route Of Administrations
3) By Application: Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders
Subsegments:
1) By Innovative: Long-Acting Peptides, Combination Peptides
2) By Generic: Monoclonal Antibodies, Hormones, Enzymes
Which Trends Are Guiding The Direction Of The Biosimilar Therapeutic Peptides Market?
Major companies in the biosimilar therapeutic peptide market are creating research platforms focused on optimizing peptide synthesis, increasing production efficiency, and ensuring uniform quality from discovery through commercialization. The Biodrug Design Accelerator serves as a platform for managing research processes in peptide drug discovery, which many consider a promising area in new drug development. For example, in May 2023, Fujitsu Limited, a US-based toy manufacturing and entertainment company, introduced the Biodrug Design Accelerator platform to expedite peptide drug discovery research. This accelerator will assist peptide drug discovery scientists in pharmaceutical companies to quicken and enhance the efficiency of peptide drug development, specifically by streamlining the design, make, test, analyze (DMTA) cycles. This ultimately leads to a faster and more informed design of peptide drug candidates and improves communication among scientists regarding synthesis and testing.
Which Players Are Present In The Biosimilar Therapeutic Peptides Market Space?
Major companies operating in the biosimilar therapeutic peptides market are Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi SA, Takeda Pharmaceuticals Co. Ltd., Eli Lilly and Company, Novo Nordisk A/S, Apotex Inc., Teva Pharmaceuticals Industries Ltd., Sandoz International GmbH, Lonza Inc., Stada Arzneimittel AG, Ipsen S.A, Biocon Biopharmaceuticals Pvt. Ltd., Dr. Reddy’s Laboratories Ltd., Alvogen Pharma US Inc., Corden Pharma GmbH, Bachem Holding AG, PolyPeptide Laboratories Ltd.
Get The Full Biosimilar Therapeutic Peptides Market Report:
Which Region Dominates The Biosimilar Therapeutic Peptides Market By Market Share?
North America was the largest region in the biosimilar therapeutics peptides market in 2025. Middle East is expected to be the fastest growing region in the biosimilar therapeutic peptides market report during the forecast period. The regions covered in the biosimilar therapeutic peptides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Biosimilar Therapeutic Peptides Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Biosimilar Therapeutic Peptides Market 2026, By The Business Research Company
Biosimilar Therapeutic Peptide Market Report 2026
Pharmaceutical Drugs And Biologics Logistics Market 2026
Therapeutic Dental Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/therapeutic-dental-equipment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model